Category: Replacement Heart Valves
An automotive engineer is trying to raise money for a new replacement heart valve he designed by turning to crowd-funding site Indiegogo.
A Salt Lake City engineer is hoping to raise money on crowdfunding website Indiegogo to back preclinical testing of the new valve replacement technology he designed.
A clinical study delivers positive results for replacement heart valves made by rivals Edwards Lifesciences and Medtronic in treating bicuspid disease.
Transcatheter Technologies says it's developing a transfemoral version of its replacement heart valve to complement its existing Trinity transapical device.
Michael Mussallem, CEO, Edwards Lifesciences says FDA regulators are looking to speed up approvals for medical devices
(Reuters) - U.S. health regulators appear open to speeding up approvals of medical devices that currently often reach European markets three to five years ahead of being cleared in the United States, the chief executive officer of Edwards Lifesciences (NYSE:EW) said.
Edwards Lifesciences affirms its outlook for 2014 and reveals its 2015 guidance, along with an increased investment in CardioKinetix and a new leader for its critical care business lured from Medtronic.
Direct Flow Medical says it raised a $32 million funding round and tapped medtech veteran Chris Richardson to be its new chief commercial officer.
Direct Flow Medical said today that it landed a $32 million funding round for its replacement heart valve technology and tapped a 25-year medical device veteran, Chris Richardson, to lead its commercialization program.
Xeltis says it raised a $34 million Series B round for its technology to regenerate coronary valves and vessels.
Xeltis said today that it closed an over-subscribed Series B round worth about $34 billion for the regenerative heart valve technology it's developing.